Wnt1 Inducible Signaling Pathway Protein 1 (WISP1) Targets PRAS40 to Govern β-Amyloid Apoptotic Injury of Microglia
Open accessAbstract
Given the present challenges to attain effective treatment for β-amyloid (Aβ) toxicity in neurodegenerative disorders such as Alzheimer's disease, development of novel cytoprotective pathways that can assist immune mediated therapies through the preservation of central nervous system microglia could offer significant promise. We show that the CCN4 protein, Wnt1 inducible signaling pathway protein 1 (WISP1), is initially up-regulated by Aβ and can modulate its endogenous expression for the protection of microglia during Aβ mediated apoptosis. WISP1 activates mTOR and phosphorylates p70S6K and 4EBP1 through the control of the regulatory mTOR component PRAS40. Loss of PRAS40 through gene reduction or inhibition by WISP1 is cytoprotective. WISP1 ultimately governs PRAS40 by sequestering PRAS40 intracellularly through post-translational phosphorylation and binding to protein 14-3-3. Our work identifies WISP1, mTOR signaling, and PRAS40 as targets for new strategies directed against Alzheimer's disease and related disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
WISP1 has been shown to be protective against oxidative stress in neurons and to block amyloid toxicity in inflammatory microglia of the brain.
“WISP1 has been shown to be protective against oxidative stress in neurons [10–12] and to block amyloid toxicity in inflammatory microglia of the brain [13].”
From Tuberous Sclerosis Protein 2 (TSC2) Modulates CCN4 Cytoprotection During Apoptotic Amyloid Toxicity in Microglia (2013) · cites this paper as [13]
WISP1 promotes cytoprotection in multiple cell types through pathways that require PI 3-K and Akt and, in microglia, involve mTOR and PRAS40.
“WISP1 promotes cytoprotection in multiple cell types through pathways that not only require phosphatidylinositol-3-kinase (PI 3-K) and protein kinase B (Akt) [7, 8, 10, 11, 20, 21], but also utilize pathways in microglia that involve the mammalian target of rapamycin (mTOR) and the proline rich Akt substrate 40 kDa (PRAS40) [13].”
From Tuberous Sclerosis Protein 2 (TSC2) Modulates CCN4 Cytoprotection During Apoptotic Amyloid Toxicity in Microglia (2013) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · see citing works
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033 · see citing works
Ma, T., Hoeffer, C. A., Capetillo-Zarate, E., Yu, F., Wong, H., Lin, M. T., Tampellini, D., Klann, E., Blitzer, R. D., & Gouras, G. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012845 · Cited by 262 · see citing works
Venkatesan, B., Prabhu, S. D., Venkatachalam, K., Mummidi, S., Valente, A. J., Clark, R. A., Delafontaine, P., & Chandrasekar, B. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.005 · Cited by 105 · see citing works
Siglec receptors and hiding plaques in Alzheimer's disease
Salminen, A., & Kaarniranta, K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0472-1 · Cited by 73 · see citing works
Reddy, V. S., Valente, A. J., Delafontaine, P., & Chandrasekar, B. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22676 · Cited by 68 · see citing works
Flagged first, then by citations
Research works printed but not linked: 76
- [1]Yeger H Perbal B The CCN family of genes: a perspective on CCN biology and therapeutic potential J Cell Commun Signal 12 2007 1 3-4 159 64 18568428 PMC2443235
- [2]Su F Overholtzer M Besser D Levine AJ WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase Genes Dev 1 1 2002 16 1 46 57 11782444 PMC155313
- [3]French DM Kaul RJ D’Souza AL Crowley CW Bao M Frantz GD WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair Am J Pathol 9 2004 165 3 855 67 15331410 PMC1618601
- [4]Macsai CE Georgiou KR Foster BK Zannettino AC Xian CJ Microarray expression analysis of genes and pathways involved in growth plate cartilage injury responses and bony repair Bone 5 2012 50 5 1081 91 22387305
- [5]Colston JT de la Rosa SD Koehler M Gonzales K Mestril R Freeman GL Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor Am J Physiol Heart Circ Physiol 9 2007 293 3 H1839 46 17616748
- [6]Heise RL Stober V Cheluvaraju C Hollingsworth JW Garantziotis S Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity J Biol Chem 20 5 2011 286 20 17435 44 21398522 PMC3093817
- [7]Wang S Chong ZZ Shang YC Maiese K Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL Curr Neurovasc Res 2 2012 9 1 20 31 22272766 PMC3274638
- [8]Wang S Chong ZZ Shang YC Maiese K WISP1 (CCN4) autoregulates its expression and nuclear trafficking of beta-catenin during oxidant stress with limited effects upon neuronal autophagy Curr Neurovasc Res 4 4 2012 9 2 89 99 PMC3354035 22475393
- [10]Bajda M Guzior N Ignasik M Malawska B Multi-target-directed ligands in Alzheimer’s disease treatment Curr Med Chem 1 11 2011 18 32 4949 75 22050745
- [11]Chong ZZ Li F Maiese K Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer’s disease Brain Res Brain Res Rev 7 2005 49 1 1 21 15960984 PMC2276700
- [12]Hong YK Lee S Park SH Lee JH Han SY Kim ST Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer’s disease model Biochem Biophys Res Commun 2 3 2012 419 1 49 53 22326868
- [13]Maiese K Chong ZZ Shang YC Wang S Translating cell survival and cell longevity into treatment strategies with SIRT1 Rom J Morphol Embryol 2011 52 4 1173 85 22203920 PMC3253557
- [14]Su SY Cheng CY Tsai TH Hsiang CY Ho TY Hsieh CL Paeonol attenuates HO-induced NF-kappaB-associated amyloid precursor protein expression Am J Chin Med 2010 38 6 1171 92 21061469
- [15]Zeng KW Wang XM Ko H Kwon HC Cha JW Yang HO Hyperoside protects primary rat cortical neurons from neurotoxicity induced by amyloid beta-protein via the PI3K/Akt/Bad/Bcl(XL)-regulated mitochondrial apoptotic pathway Eur J Pharmacol 15 12 2011 672 1-3 45 55 21978835
- [16]Delrieu J Ousset PJ Vellas B Gantenerumab for the treatment of Alzheimer’s disease Expert Opin Biol Ther 15 5 2012 22583155
- [17]Bach JP Mengel D Wahle T Kautz A Balzer-Geldsetzer M Al-Abed Y The Role of CNI-1493 in the Function of Primary Microglia with Respect to Amyloid-beta J Alzheimers Dis 1 1 2011 26 1 69 80 21593565
- [18]Fuhrmann M Bittner T Jung CK Burgold S Page RM Mitteregger G Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease Nat Neurosci 21 3 2010 PMC4072212 20305648
- [19]Rogers J Lue LF Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer’s disease Neurochem Int Nov-Dec 2001 39 5-6 333 40 11578768
- [21]Shang YC Chong ZZ Hou J Maiese K The forkhead transcription factor FoxO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3 Curr Neurovasc Res 2 2009 6 1 20 31 19355923 PMC2668140
- [22]Shang YC Chong ZZ Wang S Maiese K Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL Aging (Albany NY) 3 3 2012 4 3 187 201 22388478 PMC3348479
- [24]Shang YC Chong ZZ Wang S Maiese K Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia Curr Neurovasc Res 19 10 2011 8 4 270 85 22023617 PMC3254854
- [25]Sosunov AA Wu X McGovern RA Coughlin DG Mikell CB Goodman RR The mTOR pathway is activated in glial cells in mesial temporal sclerosis Epilepsia 6 2012 53 Suppl 1 78 86 22612812
- [26]Hernandez G Lal H Fidalgo M Guerrero A Zalvide J Force T A novel cardioprotective p38-MAPK/mTOR pathway Exp Cell Res 10 12 2011 317 20 2938 49 22001647 PMC3215777
- [27]Magri L Cambiaghi M Cominelli M Alfaro-Cervello C Cursi M Pala M Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions Cell Stem Cell 4 11 2011 9 5 447 62 22056141
- [29]Wang H Zhang Q Wen Q Zheng Y Philip L Jiang H Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway Cell Signal 1 2012 24 1 17 24 21906675
- [30]Wang L Harris TE Roth RA Lawrence JC Jr PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding J Biol Chem 6 7 2007 282 27 20036 44 17510057
- [31]Chong ZZ Maiese K Mammalian Target of Rapamycin Signaling in Diabetic Cardiovascular Disease Cardiovasc Diabetol 30 4 2012 11 1 45 22545721 PMC3398846
- [32]Das F Dey N Venkatesan B Kasinath BS Ghosh-Choudhury N Choudhury GG High glucose upregulation of early-onset Parkinson’s disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy Cell Signal 8 2011 23 8 1311 9 21426932 PMC3104472
- [33]Kapoor V Zaharieva MM Das SN Berger MR Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma Cancer Lett 1 6 2012 319 1 39 48 22202640
- [34]Wang J Xiao X Zhang Y Shi D Chen W Fu L Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells J Pineal Res 3 1 2012 22335196
- [35]Shang YC Chong ZZ Hou J Maiese K Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress Cell Signal 9 2010 22 9 1317 29 20462515 PMC2893230
- [36]Chong ZZ Li F Maiese K Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity Curr Neurovasc Res 12 2005 2 5 387 99 16375720 PMC1986681
- [37]Chong ZZ Li F Maiese K Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways Cell Signal 6 2007 19 6 1150 62 17289346 PMC1913492
- [38]Li F Chong ZZ Maiese K Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB Curr Neurovasc Res 8 2006 3 3 187 201 16918383 PMC1986678
- [39]Chong ZZ Kang JQ Maiese K Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases Circulation 3 12 2002 106 23 2973 9 12460881
- [40]Chong ZZ Kang JQ Maiese K Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways Br J Pharmacol 3 2003 138 6 1107 18 12684267 PMC1573758
- [41]Hou J Chong ZZ Shang YC Maiese K Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation Curr Neurovasc Res 5 2010 7 2 95 112 20370652 PMC2876719
- [42]Chong ZZ Hou J Shang YC Wang S Maiese K EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a, GSK-3beta, and beta-Catenin to Foster Vascular Integrity During Experimental Diabetes Curr Neurovasc Res 1 5 2011 8 2 103 20 21443457 PMC3084631
- [43]Chong ZZ Kang JQ Maiese K Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin J Cereb Blood Flow Metab 3 2003 23 3 320 30 12621307
- [44]Kang JQ Chong ZZ Maiese K Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation Mol Pharmacol 9 2003 64 3 557 69 12920191
- [45]Chong ZZ Shang YC Zhang L Wang S Maiese K Mammalian target of rapamycin: hitting the bull’s-eye for neurological disorders Oxid Med Cell Longev Nov-Dec 2010 3 6 374 91 21307646 PMC3154047
- [46]Pearson RB Dennis PB Han JW Williamson NA Kozma SC Wettenhall RE The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain Embo J 1 11 1995 14 21 5279 87 7489717 PMC394637
- [47]Magagnin MG van den Beucken T Sergeant K Lambin P Koritzinsky M Devreese B The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency Proteomics 3 2008 8 5 1019 28 18219697
- [48]Gingras AC Kennedy SG O’Leary MA Sonenberg N Hay N 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway Genes Dev 15 2 1998 12 4 502 13 9472019 PMC316523
- [49]Bhandari BK Feliers D Duraisamy S Stewart JL Gingras AC Abboud HE Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells Kidney Int 3 2001 59 3 866 75 11231341
- [50]Kovacina KS Park GY Bae SS Guzzetta AW Schaefer E Birnbaum MJ Identification of a proline-rich Akt substrate as a 14-3-3 binding partner J Biol Chem 21 3 2003 278 12 10189 94 12524439
- [51]Vander Haar E Lee SI Bandhakavi S Griffin TJ Kim DH Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 Nat Cell Biol 3 2007 9 3 316 23 17277771
- [52]Kohara H Tabata Y Enhancement of ectopic osteoid formation following the dual release of bone morphogenetic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges Biomaterials 8 2011 32 24 5726 32 21570720
- [53]Lafay-Chebassier C Paccalin M Page G Barc-Pain S Perault-Pochat MC Gil R mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer’s disease J Neurochem 7 2005 94 1 215 25 15953364
- [55]Case N Ma M Sen B Xie Z Gross TS Rubin J Beta-catenin levels influence rapid mechanical responses in osteoblasts J Biol Chem 24 10 2008 283 43 29196 205 18723514 PMC2570859
- [56]Venkatachalam K Venkatesan B Valente AJ Melby PC Nandish S Reusch JE WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death J Biol Chem 22 5 2009 284 21 14414 27 19339243 PMC2682890
- [57]Marchand A Atassi F Gaaya A Leprince P Le Feuvre C Soubrier F The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans Aging Cell 4 2011 10 2 220 32 21108734
- [58]Chong ZZ Shang YC Hou J Maiese K Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways Oxid Med Cell Longev Mar-Apr 2010 3 2 153 65 20716939 PMC2952099
- [59]Schutters K Reutelingsperger C Phosphatidylserine targeting for diagnosis and treatment of human diseases Apoptosis 9 2010 15 9 1072 82 20440562 PMC2929432
- [60]Witting A Muller P Herrmann A Kettenmann H Nolte C Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition J Neurochem 9 2000 75 3 1060 70 10936187
- [61]Chong ZZ Li F Maiese K The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection Int J Mol Med 2 2007 19 2 263 72 17203200 PMC1986680
- [62]Liu B Wang K Gao HM Mandavilli B Wang JY Hong JS Molecular consequences of activated microglia in the brain: overactivation induces apoptosis J Neurochem 4 2001 77 1 182 9 11279274
- [63]Chong ZZ Kang JQ Maiese K AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9 Exp Cell Res 10 6 2004 296 2 196 207 15149850
- [64]Dombroski D Balasubramanian K Schroit AJ Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice J Autoimmun 2000 14 3 221 9 10756084
- [65]Popescu NI Lupu C Lupu F Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure Blood 12 8 2010 116 6 993 1001 20448108 PMC2924232
- [66]Maiese K Chong ZZ Hou J Shang YC Oxidative stress: Biomarkers and novel therapeutic pathways Exp Gerontol 3 2010 45 3 217 34 20064603 PMC2827206
- [67]Pineda D Ampurdanes C Medina MG Serratosa J Tusell JM Saura J Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors Glia 4 2012 60 4 526 40 22162045
- [68]Chong ZZ Maiese K The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury Histol Histopathol 11 2007 22 11 1251 67 17647198 PMC2515712
- [69]Fokas E Yoshimura M Prevo R Higgins G Hackl W Maira SM NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/Mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity Radiat Oncol 27 3 2012 7 1 48 22452803 PMC3348043
- [70]Chen JX Tuo Q Liao DF Zeng H Inhibition of Protein Tyrosine Phosphatase Improves Angiogenesis via Enhancing Ang-1/Tie-2 Signaling in Diabetes Exp Diabetes Res 2012 2012 836759 22454630 PMC3291112
- [71]Deblon N Bourgoin L Veyrat-Durebex C Peyrou M Vinciguerra M Caillon A Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats Br J Pharmacol 4 2012 165 7 2325 40 22014210 PMC3413866
- [72]Hou J Chong ZZ Shang YC Maiese K FoxO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling Mol Cell Endocrinol 4 3 2010 321 2 194 206 20211690 PMC2857725
- [73]Maiese K Chong ZZ Hou J Shang YC The vitamin nicotinamide: translating nutrition into clinical care Molecules 2009 14 9 3446 85 19783937 PMC2756609
- [74]Hou G Xue L Lu Z Fan T Tian F Xue Y An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR Cancer Lett 18 8 2007 253 2 236 48 17360108
- [76]Ballou LM Lin RZ Rapamycin and mTOR kinase inhibitors J Chem Biol 11 2008 1 1-4 27 36 19568796 PMC2698317
- [77]Chong ZZ Shang YC Maiese K Cardiovascular Disease and mTOR Signaling Trends Cardiovasc Med 7 2011 21 5 151 5 22732551 PMC3384484
- [78]Lafay-Chebassier C Perault-Pochat MC Page G Rioux Bilan A Damjanac M Pain S The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide J Neurosci Res 1 11 2006 84 6 1323 34 16955484
- [79]Chen TJ Wang DC Chen SS Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons J Neurosci Res 1 8 2009 87 10 2297 307 19301428
- [80]Pastor MD Garcia-Yebenes I Fradejas N Perez-Ortiz JM Mora-Lee S Tranque P mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia J Biol Chem 14 8 2009 284 33 22067 78 19535330 PMC2755931
- [81]Zhang D Contu R Latronico MV Zhang J Rizzi R Catalucci D MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice J Clin Invest 8 2010 120 8 2805 16 20644257 PMC2912201
- [82]Thedieck K Polak P Kim ML Molle KD Cohen A Jeno P PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis PLoS One 2007 2 11 e1217 18030348 PMC2075366
Cited by
Sorted by citations
Chen Shang, Y., Zhong Chong, Z., Wang, S., & Maiese, K. (2013) · Current Neurovascular Research · doi:10.2174/156720213804806007 · Cited by 61 · see citing works
Self-citationWang, S., Zhong Chong, Z., Chen Shang, Y., & Maiese, K. (2013) · Current Neurovascular Research · doi:10.2174/156720213804805945 · Cited by 58 · see citing works
Self-citation
- Authors
- Chen Shang, Y., Zhong Chong, Z., Wang, S., & Maiese, K.
- Affiliations
- Rutgers Cancer Institute (US)
- Corresponding author
- Maiese, Kenneth
- Venue
- Current Neurovascular Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-10-01
- Volume
- 9
- Issue
- 4
- Pages
- 239-249
- ISSN
- 1567-2026 (ISSN-L)
- PMC
- PMC3521866
- OpenAlex
- W2155738520
- Cited by
- 66
- References
- 6
- Citations by year
- 2026: 4 · 2024: 2 · 2023: 8 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 7 · 2014: 5 · 2013: 3 · 2012: 3
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Current Neurovascular Research (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- American Heart Association
- National Institutes of Health
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke (R01NS053946)
- National Institute of Environmental Health Sciences
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Keywords
- WISP1, CCN4, PRAS40, amyloid-beta, microglia, apoptosis, Alzheimer's disease, mTOR signaling, p70S6K, 4E-BP1, post-translational phosphorylation, neuroprotection, neuroinflammation
- MeSH terms
- Cell Line, Humans, Intracellular Fluid, Phosphorylation, Protein Binding, Proto-Oncogene Proteins, Random Allocation, Up-Regulation, Amyloid beta-Peptides, Apoptosis, Microglia, Adaptor Proteins, Signal Transducing, CCN Intercellular Signaling Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review